2) Thrombin-activatable fibrinolysis inhibitor
凝血酶激活纤溶抑制物
3) thrombin activatable fibrinolysis inhibitor (TAFI)
凝血酶激活的纤溶抑制物(TAFI)
4) Thrombin Activable Fibrinolysis Inhibitor Active(TAFIa)
凝血酶激活的纤维蛋白溶解抑制物活性
1.
Study on the Levels of Thrombin Activable Fibrinolysis Inhibitor Active(TAFIa) in the Patients with Hemophilia
血友病患者凝血酶激活的纤维蛋白溶解抑制物活性(TAFIa)的检测及其临床意义
5) TAFIa(TAFI activated)
活化的凝血酶激活的纤溶抑制剂
6) thrombin-activable-fibrinolysis-inhibitor
凝血酶激活的纤溶酶抑制剂
1.
Fasting peripheral blood were obtained from all patients,and plasma thrombin-activable-fibrinolysis-inhibitor(TAFI)antigen and activity,plasmin-α2-antiplasmin(PAP),and plasmin-activator-inhibitor-1(PAI-1)were measured.
取空腹外周血,用ELISA法检测血浆中凝血酶激活的纤溶酶抑制剂(TAFI)抗原、TAFI活性、纤溶酶-α2-抗纤溶酶复合物(PAP)和纤溶酶活化物抑制剂-1(PAI-1)。
补充资料:凝血酶原激活物
凝血酶原激活物
参见"血液凝固过程"。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条